A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Aveni Foundation
Var2 Pharmaceuticals
City of Hope Medical Center
Valo Therapeutics Oy
NextPoint Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo